Lasa Supergenerics Limited — Board Meeting, 28-01-2025: Outcome of Board Meeting

The Board of Directors of Lasa Supergenerics Limited has approved the issuance of 25 lakh convertible warrants, each convertible into one equity share at a face value of ₹10, on a preferential basis. This decision is subject to necessary regulatory and shareholder approvals. Additionally, the company plans to raise funds through a rights issue not exceeding ₹49 crores. An Extraordinary General Meeting is scheduled to seek member approval for these initiatives. The appointment of a Scrutinizer for the e-voting process has also been approved to ensure transparency in the proceedings.